M. Jonas

Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study.

Robert L. Martin, B. Bacon, C. Mcwherter, 2017, The lancet. Gastroenterology & hepatology.

Comparison of fondaparinux with low molecular weight heparin for venous thromboembolism prevention in patients requiring rigid or semi‐rigid immobilization for isolated non‐surgical below‐knee injury

A. M. Veen, C. Samama, G. Kierzek, 2013, Journal of thrombosis and haemostasis : JTH.

Fatal fungemia resulting from an infected transjugular intrahepatic portosystemic shunt stent.

T. Schiano, H. Bodenheimer, A. Min, 1997, The American journal of gastroenterology.

Adult onset urea cycle disorder in a patient with presumed hepatic encephalopathy.

M. Atiq, G. Neff, M. Jonas, 2008, Journal of clinical gastroenterology.

Durability of Rifaximin Response in Hepatic Encephalopathy

T. Kaiser, D. Novick, N. Kemmer, 2012, Journal of clinical gastroenterology.

Lack of Clostridium difficile Infection in Patients Treated With Rifaximin for Hepatic Encephalopathy: A Retrospective Analysis

T. Kaiser, D. Novick, N. Kemmer, 2013, Journal of clinical gastroenterology.